| Trial | Updated / Type |
Status | Phase | Were Results Reported |
Reported Actual Enrollment |
(MeSH) Terms |
Why Stopped
Limitations And Caveats |
Annotator decisions |
|---|---|---|---|---|---|---|---|---|
| NCT00720512 2007-002886-11 Details | 2015-03-11 Interventional | 3 | 184 | Bevacizumab Calcium Fluorouracil Irinotecan Leucovorin Levoleucovorin Oxaliplatin Colorectal Neop… Colorectal Canc… | - - | |||
| NCT00290082 Details | 2015-03-11 Interventional | 3 | - | Loxapine Midazolam Psychomotor Agi… Acute Agitated … | 2 complications with midazolam - | |||
| NCT00735345 2008-001016-21 Details | 2015-03-09 Interventional | 2 | - | Cetuximab Docetaxel Esophageal Neop… Esophageal Canc… | because of safety concerns the study was terminated prematurely - | |||
| NCT00939328 Details | 2015-03-06 Interventional | 2 | 0 | Bendamustine Hy… Rituximab Leukemia Leukemia, Lymph… Leukemia, Lymph… | question was no longer committee priority - | |||
| NCT00788580 Details | 2015-03-06 Interventional | 1 | 0 | MTOR Inhibitors Sirolimus Temsirolimus Neoplasms Unspecified Adu… | Study was discontinued. - | |||
| NCT00684164 Details | 2015-03-06 Interventional | 3 | 0 | Conivaptan Hyponatremia | Unable to complete a contract with the Sponsor - | |||
| NCT00251589 Details | 2015-03-06 Interventional | 1/2 | 23 | Erlotinib Hydro… Vorinostat Carcinoma, Non-… Lung Neoplasms | This trial is being closed based on lack of substantive efficacy, slow accrual and overall
tolerance in patients treated to date. Due to the slow pace of patient accrual, failure to observe meaningful efficacy in treated patients, and overall intolerance of the combination regimen, the study was terminated prematurely on 12-Oct-2007. | |||
| NCT01518933 Details | 2015-03-05 Interventional | 2 | 20 | Silybin Silymarin Hepatitis Hepatitis A Hepatitis C Recurrence Hepatitis C Vir… | when a blind review highlighted that at least 43% of patients had a virological response - | |||
| NCT01324115 2009-013621-42 Details | 2015-03-05 Interventional | 1 | 6 | Nitroarginine Neoplasms Unspecified Adu… | Sponsor Decision - | |||
| NCT01184911 Details | 2015-03-05 Interventional | 4 | 0 | Fanasil, pyrime… Pyrimethamine Sulfadoxine Malaria Intermittent Pr… Placental Malar… | Research plan changed; no longer conducting clinical trial. - | |||
| NCT00740545 Details | 2015-03-05 Interventional | 3 | 258 | Enoxaparin Alive and Viabl… | Stopped for futility - | |||
| NCT00051701 Details | 2015-03-05 Interventional | 1/2 | - | Alemtuzumab Lymphoma Lymphoma, Non-H… Non-Hodgkins Ly… | - - | |||
| NCT02378415 Details | 2015-03-04 Interventional | 1 | 20 | Ketamine Depression Depressive Diso… Acute Depressio… | Discrepancies in medication orders - | |||
| NCT01509053 Details | 2015-03-04 Interventional | 3 | 30 | Aripiprazole Schizophrenia | - - | |||
| NCT00575978 Details | 2015-03-04 Interventional | 1/2 | 0 | Hydralazine Breast Neoplasm… Breast Cancer | IRB request - | |||
| NCT00160563 Details | 2015-03-03 Interventional | 3 | 207 | Levocetirizine Asthma | The predecessor study A00309 (NCT00152464) did not show statistical significance in time to
onset of asthma between the levocetirizine and placebo groups. - | |||
| NCT00325455 Details | 2015-03-02 Interventional | 2 | [1 Refs] | 500 | Anacetrapib Hypercholestero… Hyperlipidemias Hyperlipoprotei… Mixed Hyperlipe… | - - | ||
| NCT00072189 Details | 2015-03-02 Interventional | 2 | 17 | 7-hydroxystauro… Melanoma Recurrent Melan… Stage IV Melano… | Early termination for discouraging results Study was terminated early after the first stage of a two-stage design, allowing for early termination for discouraging results | |||
| NCT01299922 Details | 2015-02-27 Interventional | 3 | 0 | Cyclosporine Cyclosporins Mycophenolic Ac… Lupus Nephritis Nephritis | IT was impossible to find patients - | |||
| NCT00445263 Details | 2015-02-27 Interventional | 4 | 170 | Tirofiban Acute Coronary … Coronary Artery… Coronary Diseas… CORONARY DISEAS… | Because of inclusion delay - |